Spotlight
Clinical
CME
Partners
Emerging Therapies for Dry Eye Disease
Crystal Brimer, OD, and Kelly K. Nichols, OD, MPH, PhD, discuss two treatments, AZR-MD-001 and Reproxalap, that are in the pipeline to treat patients with dry eye disease (DED).
EP: 1.The Prevalence and Impact of Dry Eye Disease
EP: 2.The Impact of Dry Eye Disease on Coexisting Ocular Conditions
EP: 3.Clinical Perspectives on Standard Use of Dry Eye Disease Questionnaire
EP: 4.Diagnostic Tests for Dry Eye Disease
EP: 5.Dry Eye Treatment Approaches and the Use of Artificial Tears
EP: 6.Anti-Inflammatory Therapies for Dry Eye Disease
EP: 7.Factors to Consider in Choosing Anti-Inflammatory Therapies for Dry Eye Disease
EP: 8.Managing Patients With Dry Eye Disease Pre-Cataract or Refractive Surgery
EP: 9.Developing Treatment Algorithm for Dry Eye Disease.
EP: 10.Combining Procedural and Pharmacological Therapies in Dry Eye Disease
EP: 11.New FDA-Approved Therapies and Diagnostics for Dry Eye Disease
Now Viewing
EP: 12.Emerging Therapies for Dry Eye Disease
EP: 13.Co-Management of Dry Eye Disease
EP: 14.Clinical Pearls for Management of Dry Eye Disease
Related Videos
Related Content
